我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血浆钙调神经磷酸酶水平与左室舒张功能超声参数的相关性

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第3期
页码:
319-321,325
栏目:
临床研究
出版日期:
2018-03-25

文章信息/Info

Title:
Relationship between plasma calcineurin level and echocardiographic parameters of left ventricular diastolic function
作者:
付明强; 韩雪婷; 王艳艳; 张敬敬; 周京敏
（复旦大学附属中山医院心内科，上海 200032）
Author(s):
FU Ming-qiang;  HAN Xue-ting;  WANG Yan-yan;  ZHANG Jing-jing;  ZHOU Jing-min
(Shanghai Institute of Cardiovascular Diseases/Department of Cardiology, Zhongshan Hospital, Fudan University, 200032, Shanghai, China)
关键词:
钙调神经磷酸酶; 自发性高血压大鼠; 左室舒张功能; 超声心动描记术
Keywords:
calcineurin;  spontaneously hypertensive rat;  left ventricular diastolic function;  echocardiography
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
目的 探讨血浆钙调神经磷酸酶(calcineurin，CaN)水平与左室舒张功能超声参数的相关性。方法 6月龄自发性高血压大鼠(SHR)和Wistar大鼠各15只，采用ELISA方法检测血浆CaN和N末端脑钠肽前体（NT-proBNP）水平，通过小动物超声仪检测心脏舒张和收缩功能，分析血浆CaN水平与舒张功能超声参数的相关关系。结果 与Wistar大鼠相比，6月龄SHR收缩压显著升高［(114±10)mmHg vs.(186±14)mmHg,P<0.01］；血浆CaN水平和NT-proBNP水平均高于Wistar大鼠［(1.2±0.4)ng/ml vs.(2.1±0.5)ng/ml，P<0.01；(229±85)fmol/ml vs.(327±86)fmol/ml，P<0.01)；6月龄SHR舒张功能超声参数和Wistar大鼠相比有统计学差异(E/A：2.5±0.4 vs 1.9±0.6；E′/A′：1.39±0.17 vs. 0.82±0.47；均P<0.01)。多元线性回归分析表明CaN与NT-proBNP、E/A、E′/A′具有相关性。线性相关分析表明，SHR大鼠血浆CaN水平与体质量、收缩压、NT-proBNP水平和等容舒张时间正相关(分别r=0.688，P<0.01；r=0.758，P<0.01；r=0.983，P<0.01；r=0.577，P<0.05)，与 E/A、E′/A′负相关(分别r=-0.977，P<0.01；r=-0.929，P<0.01)，与心率、射血分数、E/E′、减速时间不相关。结论 血浆CaN水平升高与左室舒张功能不全具有相关性。
Abstract:
AIM To investigate the relationship between plasma calcineurin level and echocardiographic parameters of left ventricular diastolic function. METHODS Plasma calcineurin and NT-proBNP levels were determined by ELISA assay in 15 male spontaneously hypertensive rats (SHR) and 15 six month old Wistar rats, cardiac diastolic and systolic functions were assessed by high resolution echocardiography with a 17.5 MHz probe. The relationships between plasma calcineurin and diastolic echocardiographic parameters were analyzed by correlation analysis and multiple linear regression analysis. RESULTS Compared to six-month-old Wistar rats, systolic blood pressure of SHR was higher than 140 mmHg ［(114±10) mmHg vs.(186±14) mmHg, P<0.01］. Plasma calcineurin and NT-proBNP levels both increased in SHR than those in Wistar rats ［(2.1±0.5) ng/ml vs.(1.2±0.4) ng/ml, P<0.01; (327±86) fmol/ml vs.(229±85) fmol/ml, P<0.01］. Further, E/A ratio and E′/A′ ratio significantly decreased in the SHR group compared with those of the Wistar rats (1.9±0.6 vs. 2.5±0.4 for E/A, 0.82±0.47 vs. 1.39±0.17 for E′/A′, both P<0.01). In a multiple linear regression model including body weight, systolic blood pressure, heart rate, ejection fraction, plasma NT-proBNP level, E/A, E′/A′, E/E′, deceleration time and isovolumic relaxation time, plasma NT-proBNP level, E/A and E′/A′ were independent variables of plasma calcineurin level (standardized coefficient=0.003, P<0.01; standardized coefficient=-0.354, P<0.01; standardized coefficient=-0.135, P<0.05, respectively). Linear correlation analysis showed plasma calcineurin level positively correlated with body weight, systolic blood pressure, plasma NT-proBNP level and isovolumic relaxation time (r=0.688, P<0.01; r=0.758, P<0.01; r=0.983, P<0.01; r=0.577, P<0.05, respectively). Plasma calcineurin level negatively correlated with E/A and E′/A′ (r=-0.977, P<0.01; r=-0.929, P<0.01), while there were no correlations between plasma calcineurin level and heart rate, ejection fraction, E/E′ as well as deceleration time. CONCLUSION Plasma calcineurin level in SHR is higher than that in Wistar rats and correlated well with diastolic echocardiographic parameters, suggesting plasma calcineurin level may be a useful biomarker for assessing left ventricular diastolic dysfunction.

参考文献/References

[1]Desai CS,Colangelo LA,Liu K,et al.Prevalence, prospective risk markers,and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults:the coronary artery risk development in young adults study[J].Am J Epidemiol,2013,177(1):20-32.

[2]Kane GC,Karon BL,Mahoney DW,et al.Progression of left ventricular diastolic dysfunction and risk of heart failure[J].JAMA,2011,306(8):856-863.

[3]Fu M,Zhou J,Xu J,et al.Olmesartan attenuates cardiac hypertrophy and improves cardiac diastolic function in spontaneously hypertensive rats through inhibition of calcineurin pathway[J].J Cardiovasc Pharmacol,2014,63(3):218-226.

[4]Klee CB,Crouch TH,Krinks MH.Calcineurin: a calcium- and calmodulin-binding protein of the nervous system[J].Proc Natl Acad Sci USA,1979,76(12):6270-6273.

[5]Sakuma K,Yamaguchi A.The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle[J].J Biomed Biotechnol,2010,2010:721219.

[6]Wilkins BJ,Dai YS,Bueno OF,et al.Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy[J].Cir Res,2004,94(1):110-118.

[7]Cohen GI,Pietrolungo JF,Thomas JD,et al.A practical guide to assessment of ventricular diastolic function using Doppler echocardiography[J].J Am Coll Cardiol,1996,27(7):1753-1760.

[8]Salmasi AM,Alimo A,Jepson E,et al.Age-associated changes in left ventricular diastolic function are related to increasing left ventric-ular mass[J].Am J Hypertens,2003,16(6):473-477.

[9]Nagueh SF,Smiseth OA,Appleton CP,et al.Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography:An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J].J Am Soc Echocardiogr,2016,29(4):277-314.

[10]Shimizu Y,Uematsu M,Shimizu H,et al.Peak negative myocardial velocity gradient in early diastole as a noninvasive indicator of left ventricular diastolic function:comparison with transmitral flow velocity indices[J].J Am Coll Cardiol,1998,32(5):1418-1425.

[11]Nadorlik H,Stiver C,Khan S,et al.Correlations Between Echocardiographic Systolic and Diastolic Function with Cardiac Catheterization in Biventricular Congenital Heart Patients[J].Pediatr Cardiol,2016,37(4):765-771.

[12]Ding W,Dong M,Deng J,et al.Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway[J].Am J Physiol Heart Circ Physiol,2014,307(5):H792-H802.

[13]Wang J,Wang Y,Zhang W,et al.Phenylephrine promotes cardiac fibroblast proliferation through calcineurin-NFAT pathway[J].Front Biosci(Landmark Ed),2016,21:502-513.

[14]Wang AW,Song L,Miao J,et al.Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2,NF-κB, and calcineurin signaling pathways in mice[J].Am J Hypertens,2015,28(4):518-526.

备注/Memo

备注/Memo:
收稿日期：2017-04-18.基金项目：国家自然科学基金项目资助（81370199）；复旦大学附属中山医院青年基金项目资助（2016ZSQN09）通讯作者：周京敏，主任医师，主要从事心力衰竭基础与临床研究 Email:Zjm136@gmail.com 作者简介：付明强，住院医师，博士 Email:docfmq@163.com
更新日期/Last Update: 1900-01-01